News Archive
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular disease, today announces that the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published in the Journal of the American College of Cardiology (JACC). The findings were described as "landmark work" in the accompanying editorial in today's publication.
Nine in 10 primary care physicians say that prescription drug abuse is a moderate or big problem in their communities and nearly half say they are less likely to prescribe opioids to treat pain compared to a year ago, new Johns Hopkins Bloomberg School of Public Health research suggests.
A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection.
A strong, universal, responsive civil registration and vital statistics (CRVS) system is critical for Asia Pacific countries to recover from the COVID-19 pandemic and ensure that the most vulnerable have access to healthcare, immunization and social welfare services.
Eisai Co., Ltd. announced today that it has begun the free supply of diethylcarbamazine citrate (DEC) 100 mg tablets produced at its Vizag Plant in India to the World Health Organization in line with its commitment to help WHO in its global effort to eliminate lymphatic filariasis in targeted developing and emerging countries.
› Verified 2 days ago